mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |